-
-
-
-
-
-
-
Baird Reiterates Outperform Rating on Taysha Gene Therapies (TSHA); 'Encouraged by FDA Interactions'
-
-
-
-
-
-
-
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue
-
-
-
-
-
-
-
Taysha Gene Therapies to Release First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 11
-
-
-
-
-
-
-
Taysha Gene Therapies to Release Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 8
-
-
-
-
-
-
-
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

